Q
Qingdao Norson Biotechnology
Functional probiotics manufacturer for food and health industries
About Qingdao Norson Biotechnology
Qingdao Norson Biotechnology Co., Ltd. is a high-tech enterprise established in 2018, focusing on the research, development, production, and sales of functional probiotic core raw materials. The company serves clients across the food, health food, precision medicine, and daily chemical products industries by providing probiotic powders, fermented food strains, and comprehensive application solutions. The business model operates as both a direct manufacturer and a contract manufacturing enterprise (OEM/ODM) for products like edible probiotic powders, solid drinks, and fermented lactic acid beverages.
The company was founded by Chairman Zhang Mingjun. Under his leadership, Qingdao Norson Biotechnology has achieved significant milestones, including being recognized as a "specialized, refined, and new" enterprise in Qingdao in August 2021 and securing a 40 million yuan equity investment from the Shandong Provincial Science and Technology Innovation New Kinetic Energy Venture Capital Fund in March 2020. The company's facilities include over 8,000-9,000 square meters of standardized workshops, with nearly 2,000 square meters of GMP-compliant clean workshops. This infrastructure supports an annual production capacity of over 30 tons of probiotic powder and 6,000 tons of beverages.
Norson Biotechnology controls the entire industrial chain from strain isolation and cultivation to freeze-drying and production. The company possesses a strain bank of over 2,000 strains, with more than 100 available for industrial production. It has also established the "Qingdao Lactic Acid Bacteria Engineering Research Center" to advance technological innovation. Its client base includes notable companies in the beverage and food sectors, such as Mixue Bingcheng Co., Ltd. and Nayuki Holdings Limited. The firm markets its products globally, with a presence in North America, South America, Europe, Asia, Africa, and Oceania.
Source: Dealroom company dataNews
Open roles
Qingdao Norson Biotechnology in its local ecosystem
The Qingdao Norson Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A6 investors entered at this stage
OrbiMed- SCSunshine Insurance Group Co
- KTKunlun Trust
Horus Capital
Detong Capital
Huajin Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Qingdao Norson Biotechnology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Qingdao Norson Biotechnology on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.